Molecular MRI of Inflammation in Atherosclerosis
Open Access
- 5 November 2011
- journal article
- research article
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 5 (1) , 60-68
Abstract
Inflammatory activity in atherosclerotic plaque is a risk factor for plaque rupture and atherothrombosis and may direct interventional therapy. Inflammatory activity can be evaluated at the (sub)cellular level using in vivo molecular MRI. This paper reviews recent progress in contrast-enhanced molecular MRI to visualize atherosclerotic plaque inflammation. Various MRI contrast agents, among others ultra-small particles of iron oxide, low-molecular-weight Gd-chelates, micelles, liposomes, and perfluorocarbon emulsions, have been used for in vivo visualization of various inflammation-related targets, such as macrophages, oxidized LDL, endothelial cell expression, plaque neovasculature, MMPs, apoptosis, and activated platelets/thrombus. An enzyme-activatable magnetic resonance contrast agent has been developed to study myeloperoxidase activity in inflamed plaques. Agents creating contrast based on the chemical exchange saturation transfer mechanism were used for thrombus imaging. Transfer of these molecular MRI techniques to the clinic will critically depend on the safety profiles of these newly developed magnetic resonance contrast agents.Keywords
This publication has 54 references indexed in Scilit:
- Hyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of MacrophagesBioconjugate Chemistry, 2010
- Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesisAngiogenesis, 2010
- High-Density Lipoprotein–Based Contrast Agents for Multimodal Imaging of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosisJournal of Lipid Research, 2009
- Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic PlaquesCirculation, 2009
- Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of ThrombolysisCirculation, 2008
- Targeted PARACEST nanoparticle contrast agent for the detection of fibrinMagnetic Resonance in Medicine, 2006
- Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in AtherosclerosisCirculation, 2006
- Low dose oral cannabinoid therapy reduces progression of atherosclerosis in miceNature, 2005
- Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particlesJournal of Magnetic Resonance Imaging, 2001